Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
The Urologic Clinics of North America
|
September 14, 2000
Wilms' tumor. Overview of National Wilms' Tumor Study Group results
H L Neville, M L Ritchey
Palliative Medicine
|
October 7, 2003
The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia
H l Neville-Webbe, R E Coleman
European Journal of Cancer (Oxford, England : 1990)
|
March 30, 2010
Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease
H L Neville-Webbe, R E Coleman
Journal of Pediatric Surgery
|
May 17, 2000
Emergent abdominal decompression with patch abdominoplasty in the pediatric patient
H L Neville, K P Lally, C S Cox
British Journal of Cancer
|
February 18, 2010
Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
H L Neville-Webbe, R E Coleman, I Holen
Cancer Treatment Reviews
|
December 10, 2002
The anti-tumour activity of bisphosphonates
H L Neville-Webbe, I Holen, R E Coleman
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 15, 2006
Magnesium depletion in patients receiving cisplatin-based chemotherapy
E Hodgkinson, H L Neville-Webbe, R E Coleman
Oncology (Williston Park, N.Y.)
|
December 1, 2000
Multidisciplinary management of pediatric soft-tissue sarcoma
H L Neville, R B Raney, R J Andrassy, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
April 4, 2006
Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro
H L Neville-Webbe, C A Evans, R E Coleman, et al.
Current Pharmaceutical Design
|
February 20, 2010
Targeting RANK/RANKL in the treatment of solid tumours and myeloma
C H Buckle, H L Neville-Webbe, P I Croucher, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
The Urologic Clinics of North America
|
September 14, 2000
Wilms' tumor. Overview of National Wilms' Tumor Study Group results
H L Neville, M L Ritchey
Palliative Medicine
|
October 7, 2003
The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia
H l Neville-Webbe, R E Coleman
European Journal of Cancer (Oxford, England : 1990)
|
March 30, 2010
Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease
H L Neville-Webbe, R E Coleman
Journal of Pediatric Surgery
|
May 17, 2000
Emergent abdominal decompression with patch abdominoplasty in the pediatric patient
H L Neville, K P Lally, C S Cox
British Journal of Cancer
|
February 18, 2010
Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
H L Neville-Webbe, R E Coleman, I Holen
Cancer Treatment Reviews
|
December 10, 2002
The anti-tumour activity of bisphosphonates
H L Neville-Webbe, I Holen, R E Coleman
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 15, 2006
Magnesium depletion in patients receiving cisplatin-based chemotherapy
E Hodgkinson, H L Neville-Webbe, R E Coleman
Oncology (Williston Park, N.Y.)
|
December 1, 2000
Multidisciplinary management of pediatric soft-tissue sarcoma
H L Neville, R B Raney, R J Andrassy, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
April 4, 2006
Mechanisms of the synergistic interaction between the bisphosphonate zoledronic acid and the chemotherapy agent paclitaxel in breast cancer cells in vitro
H L Neville-Webbe, C A Evans, R E Coleman, et al.
Current Pharmaceutical Design
|
February 20, 2010
Targeting RANK/RANKL in the treatment of solid tumours and myeloma
C H Buckle, H L Neville-Webbe, P I Croucher, et al.
Page
of 2